Professor Philip Cowen
Professor of Psychopharmacology, Department of Psychiatry
Professor Cowen's research focuses on the psychopharmacology of depression. He is interested in the biochemical changes that are associated with depression and how drugs work to alleviate the symptoms that depressed patients experience.
Professor Cowen sits on the National Institute for Clinical Excellence guideline panel on anxiety and the Medical Research Council Neurosciences Board.
- Antidepressants and depression
- Serotonin (5-HT)
- Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study
- Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate
- Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
Professor Cowen has experience of print and broadcast media.